Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation. 2006

Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
Third Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Tokyo 181-8611, Japan.

Increased oxidative stress under hyperglycemia may contribute to progressive deterioration of peripheral insulin sensitivity. In this study, we investigated whether gliclazide, a second-generation sulfonylurea, can protect 3T3L1 adipocytes from insulin resistance induced by oxidative stress, and whether gliclazide can restore insulin-stimulated glucose transporter 4 (GLUT4) translocation under oxidative stress. We incubated 3T3L1 adipocytes in hydrogen peroxide to produce oxidative stress, then administered various concentrations of gliclazide, N-acetylcystein (NAC), or glibenclamide. Cells treated with these drugs were next exposed to insulin, subsequent glucose uptake was measured, and the insulin-stimulated GLUT4 translocation was monitored in living cells. We found that hydrogen peroxide treatment alone suppressed glucose uptake by insulin stimulation to 65.9%+/-7.8% of the corresponding controls (P<.01). However, addition of 0.1 to 10 micromol/L gliclazide to hydrogen peroxide-treated cells dose-dependently restored glucose uptake, with 5 micromol/L gliclazide significantly restoring glucose uptake to 93.3+/-6.6% (P<.01) even under hydrogen peroxide. Treatment with the known anti-oxidant NAC also dose-dependently (0.1-10 mmol/L) restored insulin-induced glucose uptake in the presence of hydrogen peroxide. However, glibenclamide (0.1-10 micromol/L), another second-generation sulfonylurea, failed to improve glucose uptake. Similarly, treatment with 5 micromol/L gliclazide or 10 mmol/L NAC significantly overcome the reduction in insulin-stimulated GLUT4 translocation by hydrogen peroxide (P<.01), whereas 5 micromol/L glibenclamide did not. Therefore our data regarding gliclazide further characterize its mechanism of hypoglycemic effect: the observed improvements in insulin sensitivity and in GLUT4 translocation indicate that gliclazide counters the hydrogen peroxide-induced insulin resistance in 3T3L1 adipocytes and also would further augment the hypoglycemic effect of this drug as insulinotropic sulfonylurea.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D005907 Gliclazide An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. Diabrezide,Diaglyk,Diaikron,Diamicron,Gen-Gliclazide,Gliklazid,Glyade,Glyclazide,Novo-Gliclazide,S-1702,S-852,Gen Gliclazide,Novo Gliclazide,S 1702,S 852,S1702,S852
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017667 Adipocytes Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals. Fat Cells,Lipocytes,Adipocyte,Cell, Fat,Cells, Fat,Fat Cell,Lipocyte
D051275 Glucose Transporter Type 4 A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake. GLUT-4 Protein,GLUT4 Protein,Insulin-Responsive Glucose Transporter,SLC2A4 Protein,Solute Carrier Family 2, Facilitated Glucose Transporter, Member 4 Protein,GLUT 4 Protein,Glucose Transporter, Insulin-Responsive,Insulin Responsive Glucose Transporter
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
December 1998, The Journal of biological chemistry,
Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
October 2002, Proceedings of the National Academy of Sciences of the United States of America,
Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
October 1997, The Journal of biological chemistry,
Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
July 2002, The Journal of biological chemistry,
Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
March 2003, Biochemical and biophysical research communications,
Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
February 2000, Molecular endocrinology (Baltimore, Md.),
Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
February 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
November 1997, Biochemical Society transactions,
Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
July 1998, The Journal of biological chemistry,
Tatsuhiro Shimoyama, and Shinya Yamaguchi, and Kazuto Takahashi, and Hidenori Katsuta, and Eisuke Ito, and Hiroyuki Seki, and Kenji Ushikawa, and Hiroshi Katahira, and Katsuhiko Yoshimoto, and Hideki Ohno, and Shinya Nagamatsu, and Hitoshi Ishida
October 1998, Diabetes,
Copied contents to your clipboard!